日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Molecular determinants of outcome to gemcitabine, cisplatin, and nab-paclitaxel in patients with advanced biliary tract cancer

晚期胆道癌患者接受吉西他滨、顺铂和白蛋白紫杉醇治疗后疗效的分子决定因素

Kim, Daeseong; Sim, Nam Suk; Woo, Seonjeong; Kim, Min Hwan; Lee, Choong-Kun; Hong, Seung Soo; Kim, Sung Hyun; Hwang, Ho Kyoung; Kang, Chang Moo; Lee, Woo Jung; Jo, Jung Hyun; Chung, Taek; Hwang, Sohyun; Kang, Beodeul; Kim, Jung Sun; Kwon, Chang-Il; Kim, Sangwoo; Chon, Hong Jae; Kim, Chang Gon; Park, Young Nyun; Choi, Hye Jin

Efficacy and Safety of Ifosfamide and Mesna in Metastatic Castration-Resistant Prostate Cancer after Taxane-Based Chemotherapy and Novel Hormonal Therapy Failure

异环磷酰胺和美司钠治疗紫杉烷类化疗和新型激素疗法失败后的转移性去势抵抗性前列腺癌的疗效和安全性

Kim, Chang Gon; Ko, Yeo Gyeong; Yoon, Jongjin; Lee, Chung; Beom, Seung Hoon; Choi, Young-Deuk; Han, Woong Kyu; Ham, Won Sik; Han, Hyunho; Lee, Jongsoo; Heo, Ji Eun; Kim, Daeseong; Baek, Eun Sil; Kim, Sangwoo; Jung, Minsun; Shin, Sang Joon

4-1BB(+) Tregs and inhibitory progenitor exhausted T cells confer resistance to anti-PD-L1 and anti-CTLA-4 combination therapy

4-1BB(+)调节性T细胞和抑制性祖细胞耗竭的T细胞赋予抗PD-L1和抗CTLA-4联合疗法耐药性

Cha, Junha; Kim, Chang Gon; Sim, Nam Suk; Kim, Gamin; Son, Wonrak; Kim, Dahee; Jung, Yurim; Hong, Hyun Jun; Lee, Hae Been; Kim, Jaehyung; Kim, Jinna; Yoon, Sun Och; Go, Seokhyeong; Kim, Jeongah; Seong, Euijung; Baek, Seungbyn; Kim, Kyung Hwan; Hong, Min Hee; Koh, Yoon Woo; Lee, Insuk; Kim, Hye Ryun

Pegylated granulocyte colony-stimulating factor primary prophylaxis versus no prophylaxis in patients with unresectable pancreatic cancer treated with modified-FOLFIRINOX: a randomized, open-label, multicenter, phase 2 trial

在接受改良FOLFIRINOX方案治疗的不可切除胰腺癌患者中,聚乙二醇化粒细胞集落刺激因子一级预防与不进行预防的比较:一项随机、开放标签、多中心II期试验

Lee, Choong-Kun; Kim, Ilhwan; Seo, Dong Hyun; Park, Sejung; Kim, Minjae; Lee, Sang Hun; Lee, Yong June; Kim, Jung Ho; Kim, Chang Gon; Choi, Hye Jin

Preclinical investigation of anti-tumor efficacy of allogeneic natural killer cells combined with cetuximab for head and neck squamous cell carcinoma.

异体自然杀伤细胞联合西妥昔单抗治疗头颈部鳞状细胞癌的抗肿瘤疗效的临床前研究

Kim Chaeyeon, Han Mina, Kim Gamin, Son Wonrak, Kim Jeongah, Gil Minchan, Rhee Yong-Hee, Sim Nam Suk, Kim Chang Gon, Kim Hye Ryun

Real-World Outcomes and Biomarker Analysis Based on Routine Clinical, Laboratory, and Pathologic Parameters in Metastatic or Unresectable Esophageal Cancer Treated with First-Line Anti-PD-1 Plus Fluoropyrimidine and Platinum

基于常规临床、实验室和病理参数的真实世界疗效和生物标志物分析:一线抗PD-1联合氟尿嘧啶和铂类药物治疗转移性或不可切除食管癌的疗效及生物标志物分析

Jeong, Jiyun; Seo, Seyoung; Kim, Sung-Bae; Song, Joon Seon; Kim, Hye Ryun; Cho, Byoung Chul; Jung, Minkyu; Kim, Chang Gon; Hong, Moonki; Hong, Min Hee; Park, Sook Ryun

Computed tomography-based unsupervised clustering identifies clusters associated with progression free survival in clear cell renal cell carcinoma

基于计算机断层扫描的无监督聚类分析可识别与透明细胞肾细胞癌无进展生存期相关的聚类。

Park, Jae Hyon; Choi, Daeun; Lee, Chung; Kim, Chang Gon; Kim, Sangwoo; Jung, Minsun; Yoon, Jongjin

Organ-Specific Responses to Nivolumab Plus Ipilimumab in Advanced Hepatocellular Carcinoma: A Multicenter, Retrospective Study

晚期肝细胞癌患者接受纳武利尤单抗联合伊匹木单抗治疗后器官特异性反应:一项多中心回顾性研究

Kim, Jung Sun; Kim, Youngun; Kang, Beodeul; Kim, Ilhwan; Kim, Hyeyeong; Lee, Won Suk; Hong, Jung Yong; Lim, Ho Yeong; Kim, Han Sang; Kim, Chang Gon; Jung, Sanghoon; An, Chansik; Kim, Chan; Chon, Hong Jae

Hospice and Palliative Care Response Policy During the Coronavirus Disease 2019 (COVID-19) Pandemic in South Korea

韩国在2019冠状病毒病(COVID-19)大流行期间的临终关怀和姑息治疗应对政策

Kim, Chang Gon

Single-cell analysis reveals cellular and molecular factors counteracting HPV-positive oropharyngeal cancer immunotherapy outcomes

单细胞分析揭示了阻碍HPV阳性口咽癌免疫治疗效果的细胞和分子因素

Cha, Junha; Kim, Da Hee; Kim, Gamin; Cho, Jae-Won; Sung, Euijeong; Baek, Seungbyn; Hong, Min Hee; Kim, Chang Gon; Sim, Nam Suk; Hong, Hyun Jun; Lee, Jung Eun; Hemberg, Martin; Park, Seyeon; Yoon, Sun Ock; Ha, Sang-Jun; Koh, Yoon Woo; Kim, Hye Ryun; Lee, Insuk